Lung Cancer
Lung Cancer
Advertisement
Mary GreccoNon-Small Cell Lung Cancer | February 28, 2024
A study analyzed the cost-effectiveness of two different treatment methods in NSCLC.
Read More
Mary GreccoESMO 2023: Focus on Lung Cancer | February 28, 2024
Results of a study explored the potential of automated lung tumor vascularity.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 28, 2024
A study assessed unmet needs as well as QOL and FT in survivors of NSCLC.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 28, 2024
A study assessed differences in lung cancer screening eligibility among lung cancer survivors.
Eileen Koutnik-FotopoulosNon-Small Cell Lung Cancer | February 28, 2024
Researchers evaluated the safety, tolerability, and antitumor activity of Dato-DXd in treating NSCLC.
Kaitlyn KoskoLung Cancer | February 27, 2024
After an IPPC, the incidence of second primary lung cancer is high among never-smokers.
Kaitlyn KoskoLung Cancer | February 27, 2024
Smoking cessation services can be successfully integrated into low-dose computed tomography lung cancer screening programs.
Kaitlyn KoskoSmall Cell Lung Cancer | February 27, 2024
Researchers from the US and Italy have identified a biomarker that can distinguish between SCLC and SCC.
Kaitlyn KoskoLung Cancer | February 27, 2024
The level of serum ferritin in a patient with lung cancer is an effective prognostic factor for the disease.
Eileen Koutnik-FotopoulosLung Cancer | February 26, 2024
Removal of race correction in PFTs is a priority to address the inappropriate use of race within algorithms.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 26, 2024
Depression is common in patients with lung cancer and those with type 2 diabetes.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 26, 2024
VOCs are known to be associated with lung cancer, and EGFR mutations are common in lung adenocarcinoma.
Leah LawrenceAI | February 26, 2024
Within the lung cancer realm, different types of AI are being applied to advance the understanding of the disease.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 23, 2024
A study examined the impact of the Interception-Lung program, which aims to reduce the incidence of advanced lung cancer.
Mary GreccoNon-Small Cell Lung Cancer | February 23, 2024
A study evaluated the prognosis of patients with locally advanced and metastatic NSCLC who underwent prior TKI.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 23, 2024
The study aimed to investigate the relationship between tobacco use and lung cancer.
Mary GreccoNon-Small Cell Lung Cancer | February 23, 2024
The TROPION-Lung07 trial will evaluate Dato-DXd plus pembrolizumab in patients with advanced/metastatic NSCLC.
Marisa Bittoni, PhDLung Cancer | February 22, 2024
Marisa Bittoni, PhD, talks about a large-scale study exploring factors that lead to lung cancer in patients younger than 50.
Kaitlyn KoskoNon-Small Cell Lung Cancer | February 21, 2024
Patients with NSCLC who have NTRK mutations have a survival advantage with immune checkpoint inhibitors.
Kaitlyn KoskoNon-Small Cell Lung Cancer | February 21, 2024
The first in-human study of datopotamab deruxtecan showed the optimal dose for treating NSCLC.
Advertisement
Advertisement
Advertisement
Latest News

March 1, 2024